Related Experiment Video
Updated: May 10, 2026
08:23
Visualization of Bacterial Resistance using Fluorescent Antibiotic Probes
Published on: March 2, 2020
Pyridone-conjugated monobactam antibiotics with gram-negative activity.
Matthew F Brown1, Mark J Mitton-Fry, Joel T Arcari
1Worldwide Medicinal Chemistry, ‡Computational Chemistry, §Antibacterials Research Unit, ∥Pharmacokinetics, Dynamics & Metabolism, ⊥Structural Biology, Pfizer Global Research and Development , Eastern Point Road, Groton, Connecticut 06340, United States.
Journal of Medicinal Chemistry
|June 13, 2013
Summary
Researchers designed new pyridone-conjugated monobactam analogues effective against Gram-negative bacteria like Pseudomonas aeruginosa. Pharmacokinetic studies showed favorable properties, and siderophore receptors appear to facilitate drug uptake in P. aeruginosa.
Area of Science:
- Medicinal Chemistry
- Microbiology
- Pharmacology
Background:
- The rise of antibiotic resistance in Gram-negative bacteria necessitates the development of novel antibacterial agents.
- Monobactams are a class of beta-lactam antibiotics with established antibacterial activity.
- Pyridone conjugation offers a potential strategy for modifying antibiotic properties.
Purpose of the Study:
- To design and synthesize novel pyridone-conjugated monobactam analogues.
- To evaluate the in vitro antibacterial activity of these analogues against key Gram-negative pathogens.
- To investigate the pharmacokinetic properties and potential drug uptake mechanisms of promising compounds.
Main Methods:
- Structure-aided design and chemical synthesis of pyridone-conjugated monobactam analogues.
- In vitro susceptibility testing against Gram-negative bacteria (Pseudomonas aeruginosa, Klebsiella pneumoniae, Escherichia coli).
- Rat pharmacokinetic studies to assess clearance and plasma protein binding.
- Investigation of siderophore receptor involvement (PiuA, PirA) in P. aeruginosa drug uptake.
Main Results:
- A series of pyridone-conjugated monobactam analogues were successfully synthesized.
- Compounds demonstrated in vitro antibacterial activity against clinically relevant Gram-negative species.
- Compound 17 exhibited favorable pharmacokinetic parameters, including low clearance and low plasma protein binding.
- Evidence suggests that siderophore receptors PiuA and PirA mediate drug uptake in Pseudomonas aeruginosa.
Conclusions:
- Pyridone-conjugated monobactams represent a promising class of novel antibacterial agents.
- The designed analogues show potential for treating infections caused by Gram-negative bacteria.
- Pharmacokinetic properties and specific bacterial uptake mechanisms warrant further investigation for therapeutic development.
Related Concept Videos
01:23Inhibitors of Gram-positive Cell Wall Synthesis
Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...
01:25Inhibitors of Bacterial Protein Synthesis
Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...
01:28Inhibitors of Bacterial DNA Synthesis
Bacterial pathogens depend on precise and efficient DNA replication to sustain infection. Two type II topoisomerases—DNA gyrase and topoisomerase IV—are critical to this process, as they resolve DNA supercoiling and unlink chromosomes during replication. Fluoroquinolones, synthetic derivatives of quinolones, exploit this mechanism by stabilizing the transient DNA–enzyme cleavage complex, preventing strand religation, and causing lethal double-strand breaks. These antibiotics are selectively...
01:30Bacterial Phylum Actinobacteria
Coryneform bacteria are gram-positive, aerobic, nonmotile rods that exhibit irregular, club-shaped, or V-shaped arrangements. Their V-shape results from snapping division, where the inner cell wall layer forms the cross-wall, while the outer layer remains intact until it ruptures on one side, causing the daughter cells to bend away.The primary genera are Corynebacterium and Arthrobacter. Corynebacterium includes diverse species, ranging from saprophytes to pathogens like Corynebacterium...
01:25Clinical Significance of Antibiotic Resistance
Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
01:27Combined Effects of Drugs: Synergism
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...